Sun Pharma Deal History & Licensing Activity
Sun Pharma is a large pharma headquartered in India. Over the past three years, Sun Pharma has been involved in 2 licensing and acquisition transactions, with a primary focus on Small Molecules (2 deals). The company currently has 4 active clinical trials, primarily in Dermatology.
Deals (12mo)
6
Active Trials
4
Top Modality
Small Molecules
Focus Area
Dermatology
Sun Pharma Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Sun Pharma in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| deuterated JAK inhibitor | Sun Pharmaceutical | Small Molecules | Phase 3 | acquisition | Jun 2025 |
Sun Pharma Pipeline Focus
Therapeutic areas and modalities where Sun Pharma is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Sun Pharma Strategic Signals
Key indicators of Sun Pharma's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
Strategic Priorities
Sun Pharma Clinical Pipeline
Sun Pharma has 4 active clinical trials across 2 development phases.
2
Phase 1
2
Phase 2
See How Your Asset Matches Sun Pharma's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Dermatology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Dermatology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for dermatology
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
JakInhibitorDerm Benchmarks
Upfront, milestone, and royalty benchmarks for jakinhibitorderm deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
About Sun Pharma Licensing & Deal Activity
Sun Pharma is a large pharma company based in India that has been actively engaged in licensing transactions across the biopharma landscape. With 2 deals over the past three years, Sun Pharma ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Sun Pharma include Dermatology (3 deals and trials), CNS Disorders (1 deal and trial), and Hematological Malignancies (1 deal and trial). In terms of modality, Sun Pharma has shown particular interest in small molecules, jakinhibitorderm.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Sun Pharma and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Sun Pharma's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.